Hiv-1 gp120 promotes lysosomal exocytosis in human schwann cells

Gaurav Datta, Nicole M. Miller, Zahra Afghah, Jonathan Geiger, Xuesong Chen

Research output: Contribution to journalArticle

Abstract

Human immunodeficiency virus type 1 (HIV-1) associated neuropathy is the most common neurological complication of HIV-1, with debilitating pain affecting the quality of life. HIV-1 gp120 plays an important role in the pathogenesis of HIV neuropathy via direct neurotoxic effects or indirect pro-inflammatory responses. Studies have shown that gp120-induced release of mediators from Schwann cells induce CCR5-dependent DRG neurotoxicity, however, CCR5 antagonists failed to improve pain in HIV- infected individuals. Thus, there is an urgent need for a better understanding of neuropathic pain pathogenesis and developing effective therapeutic strategies. Because lysosomal exocytosis in Schwann cells is an indispensable process for regulating myelination and demyelination, we determined the extent to which gp120 affected lysosomal exocytosis in human Schwann cells. We demonstrated that gp120 promoted the movement of lysosomes toward plasma membranes, induced lysosomal exocytosis, and increased the release of ATP into the extracellular media. Mechanistically, we demonstrated lysosome de-acidification, and activation of P2X4 and VNUT to underlie gp120-induced lysosome exocytosis. Functionally, we demonstrated that gp120-induced lysosome exocytosis and release of ATP from Schwann cells leads to increases in intracellular calcium and generation of cytosolic reactive oxygen species in DRG neurons. Our results suggest that gp120-induced lysosome exocytosis and release of ATP from Schwann cells and DRG neurons contribute to the pathogenesis of HIV-1 associated neuropathy.

Original languageEnglish (US)
Article number329
JournalFrontiers in Cellular Neuroscience
Volume13
DOIs
StatePublished - Jul 16 2019

Fingerprint

Schwann Cells
Exocytosis
Lysosomes
HIV-1
Diagnosis-Related Groups
Adenosine Triphosphate
HIV
Neurons
Pain
Neuralgia
Demyelinating Diseases
Reactive Oxygen Species
Quality of Life
Cell Membrane
Calcium

Keywords

  • ATP
  • DRG neuron
  • Gp120
  • Lysosome exocytosis
  • P2X4
  • Schwann cell

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Hiv-1 gp120 promotes lysosomal exocytosis in human schwann cells. / Datta, Gaurav; Miller, Nicole M.; Afghah, Zahra; Geiger, Jonathan; Chen, Xuesong.

In: Frontiers in Cellular Neuroscience, Vol. 13, 329, 16.07.2019.

Research output: Contribution to journalArticle

Datta, Gaurav ; Miller, Nicole M. ; Afghah, Zahra ; Geiger, Jonathan ; Chen, Xuesong. / Hiv-1 gp120 promotes lysosomal exocytosis in human schwann cells. In: Frontiers in Cellular Neuroscience. 2019 ; Vol. 13.
@article{f624a0dbb39a49d38ba322cd9454bc8f,
title = "Hiv-1 gp120 promotes lysosomal exocytosis in human schwann cells",
abstract = "Human immunodeficiency virus type 1 (HIV-1) associated neuropathy is the most common neurological complication of HIV-1, with debilitating pain affecting the quality of life. HIV-1 gp120 plays an important role in the pathogenesis of HIV neuropathy via direct neurotoxic effects or indirect pro-inflammatory responses. Studies have shown that gp120-induced release of mediators from Schwann cells induce CCR5-dependent DRG neurotoxicity, however, CCR5 antagonists failed to improve pain in HIV- infected individuals. Thus, there is an urgent need for a better understanding of neuropathic pain pathogenesis and developing effective therapeutic strategies. Because lysosomal exocytosis in Schwann cells is an indispensable process for regulating myelination and demyelination, we determined the extent to which gp120 affected lysosomal exocytosis in human Schwann cells. We demonstrated that gp120 promoted the movement of lysosomes toward plasma membranes, induced lysosomal exocytosis, and increased the release of ATP into the extracellular media. Mechanistically, we demonstrated lysosome de-acidification, and activation of P2X4 and VNUT to underlie gp120-induced lysosome exocytosis. Functionally, we demonstrated that gp120-induced lysosome exocytosis and release of ATP from Schwann cells leads to increases in intracellular calcium and generation of cytosolic reactive oxygen species in DRG neurons. Our results suggest that gp120-induced lysosome exocytosis and release of ATP from Schwann cells and DRG neurons contribute to the pathogenesis of HIV-1 associated neuropathy.",
keywords = "ATP, DRG neuron, Gp120, Lysosome exocytosis, P2X4, Schwann cell",
author = "Gaurav Datta and Miller, {Nicole M.} and Zahra Afghah and Jonathan Geiger and Xuesong Chen",
year = "2019",
month = "7",
day = "16",
doi = "10.3389/fncel.2019.00329",
language = "English (US)",
volume = "13",
journal = "Frontiers in Cellular Neuroscience",
issn = "1662-5102",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Hiv-1 gp120 promotes lysosomal exocytosis in human schwann cells

AU - Datta, Gaurav

AU - Miller, Nicole M.

AU - Afghah, Zahra

AU - Geiger, Jonathan

AU - Chen, Xuesong

PY - 2019/7/16

Y1 - 2019/7/16

N2 - Human immunodeficiency virus type 1 (HIV-1) associated neuropathy is the most common neurological complication of HIV-1, with debilitating pain affecting the quality of life. HIV-1 gp120 plays an important role in the pathogenesis of HIV neuropathy via direct neurotoxic effects or indirect pro-inflammatory responses. Studies have shown that gp120-induced release of mediators from Schwann cells induce CCR5-dependent DRG neurotoxicity, however, CCR5 antagonists failed to improve pain in HIV- infected individuals. Thus, there is an urgent need for a better understanding of neuropathic pain pathogenesis and developing effective therapeutic strategies. Because lysosomal exocytosis in Schwann cells is an indispensable process for regulating myelination and demyelination, we determined the extent to which gp120 affected lysosomal exocytosis in human Schwann cells. We demonstrated that gp120 promoted the movement of lysosomes toward plasma membranes, induced lysosomal exocytosis, and increased the release of ATP into the extracellular media. Mechanistically, we demonstrated lysosome de-acidification, and activation of P2X4 and VNUT to underlie gp120-induced lysosome exocytosis. Functionally, we demonstrated that gp120-induced lysosome exocytosis and release of ATP from Schwann cells leads to increases in intracellular calcium and generation of cytosolic reactive oxygen species in DRG neurons. Our results suggest that gp120-induced lysosome exocytosis and release of ATP from Schwann cells and DRG neurons contribute to the pathogenesis of HIV-1 associated neuropathy.

AB - Human immunodeficiency virus type 1 (HIV-1) associated neuropathy is the most common neurological complication of HIV-1, with debilitating pain affecting the quality of life. HIV-1 gp120 plays an important role in the pathogenesis of HIV neuropathy via direct neurotoxic effects or indirect pro-inflammatory responses. Studies have shown that gp120-induced release of mediators from Schwann cells induce CCR5-dependent DRG neurotoxicity, however, CCR5 antagonists failed to improve pain in HIV- infected individuals. Thus, there is an urgent need for a better understanding of neuropathic pain pathogenesis and developing effective therapeutic strategies. Because lysosomal exocytosis in Schwann cells is an indispensable process for regulating myelination and demyelination, we determined the extent to which gp120 affected lysosomal exocytosis in human Schwann cells. We demonstrated that gp120 promoted the movement of lysosomes toward plasma membranes, induced lysosomal exocytosis, and increased the release of ATP into the extracellular media. Mechanistically, we demonstrated lysosome de-acidification, and activation of P2X4 and VNUT to underlie gp120-induced lysosome exocytosis. Functionally, we demonstrated that gp120-induced lysosome exocytosis and release of ATP from Schwann cells leads to increases in intracellular calcium and generation of cytosolic reactive oxygen species in DRG neurons. Our results suggest that gp120-induced lysosome exocytosis and release of ATP from Schwann cells and DRG neurons contribute to the pathogenesis of HIV-1 associated neuropathy.

KW - ATP

KW - DRG neuron

KW - Gp120

KW - Lysosome exocytosis

KW - P2X4

KW - Schwann cell

UR - http://www.scopus.com/inward/record.url?scp=85069482449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069482449&partnerID=8YFLogxK

U2 - 10.3389/fncel.2019.00329

DO - 10.3389/fncel.2019.00329

M3 - Article

VL - 13

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

SN - 1662-5102

M1 - 329

ER -